Free tool
Healthcare stocks
We cover 14 companies in the Healthcare sector. The median market value in the group is $261.30B. Across the group, the median move over the past trading day is +1.64%. Price change over the past year runs from −9.8% to +69.5% across the middle 80 percent of the group, with a median of +29.3%.
Other lists in this group
Table
14 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| NVO.WA | Novo Nordisk A/S | 175.12 PLN | −10.34% | −1.45% | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.